Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Veracyte (VCYT) Revenue: 2012-2025

Historic Revenue for Veracyte (VCYT) over the last 13 years, with Sep 2025 value amounting to $131.9 million.

  • Veracyte's Revenue rose 13.82% to $131.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $495.1 million, marking a year-over-year increase of 16.41%. This contributed to the annual value of $445.8 million for FY2024, which is 23.46% up from last year.
  • According to the latest figures from Q3 2025, Veracyte's Revenue is $131.9 million, which was up 1.31% from $130.2 million recorded in Q2 2025.
  • Veracyte's Revenue's 5-year high stood at $131.9 million during Q3 2025, with a 5-year trough of $36.7 million in Q1 2021.
  • Its 3-year average for Revenue is $107.6 million, with a median of $114.4 million in 2024.
  • Data for Veracyte's Revenue shows a peak YoY spiked of 166.16% (in 2021) over the last 5 years.
  • Over the past 5 years, Veracyte's Revenue (Quarterly) stood at $67.3 million in 2021, then rose by 19.25% to $80.3 million in 2022, then grew by 22.29% to $98.2 million in 2023, then increased by 20.81% to $118.6 million in 2024, then climbed by 13.82% to $131.9 million in 2025.
  • Its Revenue was $131.9 million in Q3 2025, compared to $130.2 million in Q2 2025 and $114.5 million in Q1 2025.